World of DTC Marketing
DECEMBER 29, 2021
The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.
pharmaphorum
DECEMBER 29, 2021
Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma’s rival antibody tralokinumab. IL-13 inhibitor tralokinumab has been cleared by the US regulator as Adbry as a treatment for moderate-to-severe atopic dermatitis in adults who can’t control symptoms using topical prescription therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
DECEMBER 29, 2021
UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Credit: Picturing Health, picturinghealth.org UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Peer-reviewed / Randomised controlled trial / People Easy-to-take medicine better at suppressing HIV in children A once-a-day […].
XTalks
DECEMBER 29, 2021
Bayer has announced that all of its products will have 100 percent green packaging by 2030. The pharma giant says it will be investing €100 million towards achieving this target, which is part of the company’s sustainability program aimed at helping to protect the environment and combat climate change. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or re
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Scienmag
DECEMBER 29, 2021
New research involving 149 participants found no evidence that vitamin D supplementation taken over six months improves mental or physical health symptoms in people with psychosis. Participants did however show high rates of vitamin D deficiency which could have longer term health impacts not captured in the study, according to researchers. Credit: Helin Loik-Tomson New […].
BioTech 365
DECEMBER 29, 2021
Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Mission Viejo, California, United States, Dec.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
DECEMBER 29, 2021
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
DECEMBER 29, 2021
What The Study Did: In this study that included nearly 12,000 patients with obesity, substantial weight loss achieved with weight loss surgery was associated with improved outcomes after contracting COVID-19 infection, including a lower risk of severe disease, hospitalization and need for supplemental oxygen. Authors: Steven E. Nissen, M.D., of the Cleveland Clinic, is the […].
BioTech 365
DECEMBER 29, 2021
United States Artificial Intelligence (AI) In Drug Discovery Market Research Report 2021: Prospects, Trends Analysis, Market Size and Forecasts to 2027 – ResearchAndMarkets.
Scienmag
DECEMBER 29, 2021
WASHINGTON — Scientists at the U.S. Naval Research Laboratory evaluate early data the ESA/NASA Solar Orbiter spacecraft sent back to Earth as it observes comet Leonard, a mass of space dust, rock and ice just over half a mile across (1 kilometer) as it heads inbound to the sun. Credit: NASA/NRL/Karl Battams WASHINGTON — Scientists […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioTech 365
DECEMBER 29, 2021
ImmunoGen Announces Webcast of Presentation and Q&A at the 40th Annual J.P. Morgan Healthcare Conference ImmunoGen Announces Webcast of Presentation and Q&A at the 40th Annual J.P. Morgan Healthcare Conference WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc.
Scienmag
DECEMBER 29, 2021
Dr. HUO Zhipeng and his student ZHAO Sheng from the Hefei Institutes of physical science (HFIPS) of the Chinese Academy of Sciences recently developed a lead-free neutron and gamma ray composite shielding material that has high shielding properties and is environmentally friendly. Their results were published on Nuclear Materials and Energy. Credit: HUO Zhipeng Dr.
BioTech 365
DECEMBER 29, 2021
Select Walmart and Sam’s Club Pharmacies Ready To Dispense Authorized COVID-19 Antiviral Medication Through Federal Retail Pharmacy Therapeutics Program Select Walmart and Sam’s Club Pharmacies Ready To Dispense Authorized COVID-19 Antiviral Medication Through Federal Retail Pharmacy Therapeutics Program Walmart launches … Continue reading →
Scienmag
DECEMBER 29, 2021
Reported in three major soybean-producing countries in South America (Argentina, Brazil, and Paraguay), Cercospora leaf blight (CLB) is a global threat to soybean. CLB causes dark-purple lesions on leaves and premature defoliation, which can diminish soybean production. Currently there are no CLB-resistant soybean cultivars, and fungicides are becoming less effectiveness as CLB develops resistance.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioTech 365
DECEMBER 29, 2021
Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST® Rapid COVID-19 Antigen Self-Test Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST® Rapid COVID-19 Antigen Self-Test The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for … Continue reading →
Scienmag
DECEMBER 29, 2021
COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian. The researchers, whose study was published […].
BioTech 365
DECEMBER 29, 2021
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of … Continue reading →
Scienmag
DECEMBER 29, 2021
A team led by Prof. HU Linhua at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS) has recently developed a type of self-healing perovskite solar cell by functional combination of polyvinylpyrrolidone (PVP). Related results were published in Journal of Energy Chemistry. Credit: NIU Yunjuan A team led by Prof. HU Linhua at the Hefei […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioTech 365
DECEMBER 29, 2021
BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under ‘BCT’; Remains ‘BCTX’ on Nasdaq BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under ‘BCT’; Remains ‘BCTX’ on Nasdaq … Continue reading →
Scienmag
DECEMBER 29, 2021
Researchers at Columbia University Mailman School of Public Health found marked decreases in orphanhood particularly double orphanhood, among adolescents in Rakai, Uganda, corresponding with the availability of antiretroviral therapy (ART) beginning in 2004 and of male medical circumcision in 2007. Until now, little had been known about the contribution of HIV combination prevention including ART […].
BioTech 365
DECEMBER 29, 2021
RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous 30-Dec-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Relief Reports that its U.S.
Scienmag
DECEMBER 29, 2021
UCLA Jonsson Comprehensive Cancer Center researchers leading a meta-analysis of seven randomized trials found an “unexpected result”: Although Black men appeared to have more aggressive disease when they enrolled in clinical trials of radiation therapy for prostate cancer, their treatment outcomes and disease-specific outcomes were better than those of their white counterparts.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioTech 365
DECEMBER 29, 2021
Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous 30-Dec-2021 / 06:00 GMT/BST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art.
Scienmag
DECEMBER 29, 2021
Wednesday, December 29, 2021, 11 am ET, CLEVELAND: A Cleveland Clinic study shows that among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of developing severe complications from COVID-19 infection. The research was published in the journal JAMA Surgery. Numerous studies have established obesity as a […].
BioTech 365
DECEMBER 29, 2021
Polyphor AG / Key word(s): Merger 30-Dec-2021 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art.
Scienmag
DECEMBER 29, 2021
What The Study Did: This study combined the results of seven randomized clinical trials with 8,000 patients to compare the overall and treatment-specific outcomes of Black and white men with localized prostate cancer who received radiation therapy. Authors: Amar U. Kishan, M.D., of the University of California, Los Angeles, is the corresponding author.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
DECEMBER 29, 2021
[
Scienmag
DECEMBER 29, 2021
Safer carbon capture and storage Atmospheric carbon dioxide (CO2) levels have increased significantly over the last 50 years, resulting in higher global temperatures and abrupt changes to Earth’s climate. Carbon capture and storage (CCS) is one of the new technologies that scientists hope will play an important role in tackling the climate crisis. It involves the capture […].
BioTech 365
DECEMBER 29, 2021
The Worldwide Fertility Services Industry is Expected to Reach $39 Billion by 2027 – ResearchAndMarkets.com The Worldwide Fertility Services Industry is Expected to Reach $39 Billion by 2027 – ResearchAndMarkets.
Scienmag
DECEMBER 29, 2021
Experiments attempting to explain why bats can be infected with many viruses at a time without succumbing to diseases such as COVID-19—knowledge that could help us to reduce the threat to humans of infectious disease—have struggled until now with the fact that live wild bats make poor research subjects. To overcome this obstacle, for the […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
191 
Let's personalize your content